Pharmaceutical composition for treating a β-catenin mediated disorder selected from the group consisting of fibroproliferative disorders and cancer

• 收藏
• 分享

专利权人:

ザ・ホスピタル・フォー・シック・チルドレン

发明人:

アルマン，ベンジャミン・エイ,プーン，レイモンド,ホン，ヘレン,アルマン,ベンジャミン・エイ,プーン,レイモンド,ホン,ヘレン

申请号：

JP2012543426

公开号：

JP5792185B2

申请日:

2010.12.15

申请国别(地区):

JP

年份:

2015

代理人:

摘要：

Methods of treating disorders mediated by &bgr；-catenin comprising administration of Nefopam compounds are provided In particular, the treatment of disorders arising from excessive or undesired expression of &bgr；-catenin is contemplated Said compounds include Nefopam, analogues thereof, prodaigs thereof, and salts and solvates of Nefopam The &bgr；-catenin mediated disorders are preferably selected from the group consisting of fibroproliferative disorders (such as scars, aggressive fibramtoses, and fibroses) and cancer (such as colon cancer, melanoma, liver cancer, ovarian cancer, endometrial cancer, medullobalstoma pilomatricomas, and prostate cancer)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/